pleuravac - pleuropneumonia vaccine for pigs
intervet australia pty limited - isotonic medium not less than 18 hu/ml haemolysin toxoid; actinobacillus pleuropneumoniae serovar 15; actinobacillus pleuropneumoniae serovar 1; formaldehyde; thiomersal - parenteral liquid/solution/suspension - isotonic medium not less than 18 hu/ml haemolysin toxoid ungrouped active 0.0 p; actinobacillus pleuropneumoniae serovar 15 vaccine-microbial active 0.0 p; actinobacillus pleuropneumoniae serovar 1 vaccine-microbial active 0.0 p; formaldehyde aldehyde other 0.05 mg/ml; thiomersal mercury other 0.1 mg/ml - immunotherapy - pigs | boar | gilt | piglet | sow | swine - actinobacillus pleuropneumoniae (haemoph | vaccine | equine rotavirus
porcilis appvac pleuropneumonia vaccine for pigs
intervet australia pty limited - actinobacillus pleuropneumoniae serovar 15; actinobacillus pleuropneumoniae serovar 1; actinobacillus pleuropneumonie serovar 7; haemolysin toxoid; formaldehyde; thiomersal - misc. vaccines or anti sera - actinobacillus pleuropneumoniae serovar 15 vaccine-microbial active 0.0 units/ml; actinobacillus pleuropneumoniae serovar 1 vaccine-microbial active 0.0 units/ml; actinobacillus pleuropneumonie serovar 7 vaccine-microbial active 0.0 units/ml; haemolysin toxoid vaccine-toxoid active 18.0 hu/ml; formaldehyde aldehyde other 0.05 mg/ml; thiomersal mercury other 0.1 mg/ml - immunotherapy - pigs | boar | gilt | piglet | sow | swine - actinobacillus pleuropneumoniae (haemoph
apvma veterinary use permit 12502- actinobacillus pleuropneumoniae/ pigs/ a. pleuropneumoniae infections
apvma permit - a. pleuropneumoniae - vaccine
apvma veterinary use permit 12550- custom actinobacillus pleuropneumoniae vaccine/ pleuropneumonia/ pigs
apvma permit - a. pleuropneumoniae - vaccine
apvma veterinary use permit 83960-actinobacillus pleuropnuemoniae/ pigs/ pleuropnuemonia
apvma permit - a. pleuropneumoniae - vaccine
parapleuro shield p ormulation: each 2 ml contains: actinobacillus pleuropneumoniae, strain 80-1144 - gli (serotype 1) 21.27 od (600 nm) actinobacillus pleuropneumoniae, strain 81-1319 - gl4 (serotype 5) >i.26 od (600 nm) actinobacillus pleuropneumoniae, strain 5751-7 - gl34 (serotype 7) >i.37 od (600 nm) glaesserella parasuis >i.53 od (600 nm) pasteurella multocida serotype a, strain 169 26.3 x 10°cfu (0.28 ml) solution for injection (im)
elanco philippines, inc.; distributor: elanco philippines, inc. - inactivated actinobacillus pleuropneumoniae , glaesserella parasuis , pasteurella multocida bacterin - solution for injection (im) - ormulation: each 2 ml contains: actinobacillus pleuropneumoniae, strain 80-1144 - gli (serotype 1) 21.27 od (600 nm) actinobacillus pleuropneumoniae, strain 81-1319 - gl4 (serotype 5) >i.26 od (600 nm) actinobacillus pleuropneumoniae, strain 5751-7 - gl34 (serotype 7) >i.37 od (600 nm) glaesserella parasuis >i.53 od (600 nm) pasteurella multocida serotype a, strain 169 26.3 x 10°cfu (0.28 ml)
neumosuin formulation: each 2 ml (dose) contains: pasteurella multocida (type a)... ............ 8 x 10^9 actinobacillus pleuropneumoniae (serotype 2) ............ >1/4 mat titer actinobacillus pleuropneumoniae (serotype 4)............. >1/4 mat titer actinobacillus pleuropneumoniae (serotype 5) ............. > 1/4 mat titer mat - microagglutination test suspension for injection (im)
hipra philippines, inc.; distributor: hipra philippines, inc. - inactivated pasteurella multocida , actinobacillus pleuropneumoniae vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: pasteurella multocida (type a)... ............ 8 x 10^9 actinobacillus pleuropneumoniae (serotype 2) ............ >1/4 mat titer actinobacillus pleuropneumoniae (serotype 4)............. >1/4 mat titer actinobacillus pleuropneumoniae (serotype 5) ............. > 1/4 mat titer mat - microagglutination test
suigen prdc formulation: each 1 ml (dose) contains: bordetella bronchiseptica -1 od bordetella bronchiseptica (dnt)-200 ug/ml pasteurella multocida (type a and d)-i od p. multocida type a (omp)-30 ug/ml actinobacillus pleuropneumoniae (serotype 2 and 5)-1 od p. multocida type d (dnt)-200 ug/ml mycoplasma hvopneumoniae-0.12 od a. pleuropneumoniae serotype 2 and 5 (toxin) 10 ug/ml streptococcus suis (type 2)-0.45 od haemophilus parasuis (serotype 1, 4 and 5)-0.45 od od - optical density at 410 nm absorbance (elisa) dnt – dermonecrotic toxin omp - outer membrane protein suspension for injection (im)
virbac philippines inc.; distributor: virbac philippines inc. - inactivated bordetella bronchiseptica , pasteurella multocida , actinobacillus pleuropneumoniae , mycoplasma hyopneumoniae , streptococcus suis , haemophilus parasuis vaccine (vet.) - suspension for injection (im) - formulation: each 1 ml (dose) contains: bordetella bronchiseptica -1 od bordetella bronchiseptica (dnt)-200 ug/ml pasteurella multocida (type a and d)-i od p. multocida type a (omp)-30 ug/ml actinobacillus pleuropneumoniae (serotype 2 and 5)-1 od p. multocida type d (dnt)-200 ug/ml mycoplasma hvopneumoniae-0.12 od a. pleuropneumoniae serotype 2 and 5 (toxin) 10 ug/ml streptococcus suis (type 2)-0.45 od haemophilus parasuis (serotype 1, 4 and 5)-0.45 od od - optical density at 410 nm absorbance (elisa) dnt – dermonecrotic toxin omp - outer membrane protein
suigen app+pm formulation: each 2 ml (dose) contains: actinobacillus pleuropneumoniae type 1, 2 and 5 ....... >10^ 9.2 cfu before inactivation pasteurella multocida, type d (pm-18 strain) ......... >10^ 9.2 cfu before inactivation cfu - colony forming unit suspension for injection (im)
virbac phillippines inc. - inactivated actinobacillus pleuropneumoniae , pasteurella multocida vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: actinobacillus pleuropneumoniae type 1, 2 and 5 ....... >10^ 9.2 cfu before inactivation pasteurella multocida, type d (pm-18 strain) ......... >10^ 9.2 cfu before inactivation cfu - colony forming unit
suishot apm-7 each 1 ml (dose) contains: pasteurella multocida, type a (nspa strain) .......... 2,000,000,000 cfu type d (pdnt strain) ........ ... 2,000,000,000 cfu actinobacillus pleuropneumoniae, serotype 2 (nsa252 strain)........... 1,000,000,000 cfu serotype 5 (nsas strain) .............. 1,000,000,000 cfu serotype 2 toxin (nsa252 strain) ... 10 ug serotype 5 toxin (nsa5 strain) ....... 10 ug cfu -colony forming unit suspension for injection (im)
agrimate, inc.; distributor: agrimate, inc. - inactivated pasteurella multocida , actinobacillus pleuropneumoniae toxoid vaccine (vet.) - suspension for injection (im) - each 1 ml (dose) contains: pasteurella multocida, type a (nspa strain) .......... 2,000,000,000 cfu type d (pdnt strain) ........ ... 2,000,000,000 cfu actinobacillus pleuropneumoniae, serotype 2 (nsa252 strain)........... 1,000,000,000 cfu serotype 5 (nsas strain) .............. 1,000,000,000 cfu serotype 2 toxin (nsa252 strain) ... 10 ug serotype 5 toxin (nsa5 strain) ....... 10 ug cfu -colony forming unit